A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

July 8, 2020

Study Completion Date

July 8, 2020

Conditions
Migraine
Interventions
DRUG

Eptinezumab

Injection for IV administration

DRUG

Placebo

Injection for IV administration

Trial Locations (57)

11229

Integrative Clinical Trials, Brooklyn

14226

Dent Neurologic Institute - Amherst, Amherst

15478

Frontier Clinical Rsearch LLC, Smithfield

20052

The George Washington Medical Faculty Associates, Washington D.C.

29464

Coastal Carolina Research Center - Mount Pleasant, Mt. Pleasant

30030

iResearch Atlanta, LLC, Decatur

30328

Office of Doctor Frank Berenson, Atlanta

31405

Meridian Clinical Research - Savannah Neurology Specialists, Savannah

32751

Meridien Research - Maitland, Maitland

33009

Medicinae Doctor Clinical, Hallandale

33012

AGA Clinical trials, Hialeah

33407

Palm Beach Neurology and Premiere Research Institute, West Palm Beach

33880

Clinical Research of Central Florida, Winter Haven

35235

Alabama Clinical Therapeutics, Birmingham

37404

Chattanooga Medical research LLC, Chattanooga

37421

WR-ClinSearch LLC, Chattanooga

37660

Holston Medical Group - Kingsport, Kingsport

39157

Headache Neurology Research Institute, Ridgeland

40509

Central Kentucky Research Associates, Lexington

43213

Aventiv Research - Columbus, Columbus

44720

Neuro-Behavioral Clinical Research Inc, North Canton

45212

CTI Clinical Research center, Cincinnati

45424

Hometown Urgent Care And Research - Huber Heights, Dayton

48104

Michigan Head Pain and Neurological institute, Ann Arbor

54956

Neuroscience Group, Neenah

55402

Clinical Research Institute - Minneapolis, Minneapolis

60607

Cedar Crosse Research Center, Chicago

63303

StudyMetrix Research, City of Saint Peters

65810

Clinvest Research, Springfield

66208

Phoenix Medical Research, Prairie Village

66212

College Park Family Care Center Physicians, Overland Park

72205

Baptist Health Center for Clinical Research, Little Rock

74133

Delricht Research, Tulsa

76104

Ventavia Research Group, LLC, Fort Worth

76248

Ventavia Research Group, LLC, Keller

77081

Texas Center for Drug Development Inc, Houston

80045

University of Colorado Hospital, Aurora

80210

Denver Neurological Clinic - Denver, Denver

84109

J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City

85053

Arizona Research Center, Phoenix

87102

Albuqerque Clinical Trials, Albuquerque

89113

Nevada Headache Institute, Las Vegas

92011

The Neurology Center of Southern California - Carlsbad, Carlsbad

92056

Excell research Inc, Oceanside

92374

Anderson Clinical Research, Redlands

92805

Advanced Research Center, Anaheim

97210

Summit Research Network, Portland

98007

Northwest Clinical Research Center, Bellevue

06320

Coastal Connecticut Research LLC, New London

06905

Ki Health Partners LLC, dba New England Institute for Clinical Research, Stamford

02131

Boston Clinical Trials, Boston

02451

MedVadis Research Corporation, LLC, Waltham

Unknown

"Ltd Acad Fridon Todua Medical Center - Ltd Research Institute of Clinical Medicine", Tbilisi

"Ltd Aversi Clinic", Tbilisi

"Ltd Multiprofile Clinica Consilium Medulla", Tbilisi

Ltd Simon Khechinashvili University Clinic, Tbilisi

"td Israel-Georgia Medical Research Clinic Helsicore", Tbilisi

Sponsors
All Listed Sponsors
collaborator

Alder Biopharmaceuticals, Inc.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY

NCT04152083 - A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine | Biotech Hunter | Biotech Hunter